Health Ministry registers AstraZeneca-SKBio vaccine for emergency use
The Ukrainian Ministry of Health registered the Korean-made AstraZeneca-SKBio vaccine against COVID-19 for emergency medical use on April 20, the ministry said on Facebook on Wednesday.
According to the report, AstraZeneca-SKBio is developed by the University of Oxford and the British-Swedish company AstraZeneca. It is produced in the Republic of Korea (SK Bioscience Co. Ltd) and has the trade name AstraZeneca-SKBio. An emergency vaccine has already been approved by the World Health Organization (WHO). The UK, the European Union, India and Canada have also given permission to use it.
Advertising
Advertising
MORE ABOUT
Vaccination with AstraZeneca-SKBio to begin in most regions on Wednesday – Liashko
15:36, 23.04.2021
Ukraine receives 2nd batch of coronavirus vaccine, over 367,000 doses - Health Ministry
10:10, 23.04.2021
LATEST
Americans and Ukrainians agree on framework of security arrangements, discuss necessary deterrence capabilities to sustain lasting peace – Dept of State
16:53, 06.12.2025
Rubio's deputy sharply criticizes EU countries after NATO meeting, Musk calls for dissolution of European Union
16:32, 06.12.2025
GUR Cyber Corps attacks leading Russian logistics company on Ukrainian Armed Forces Day – sources
16:23, 06.12.2025
AFU General Staff: Ryazan Oil Refinery in Russia, shell casing plant in occupied Alchevsk damaged
16:19, 06.12.2025
Zelenskyy: Today, the best gift for all of Ukraine would be just peace